All News

RheumNow Podcast square

RheumNow Podcast – Heart, Lung & Liver (5.28.2021)

Jack Cush, MD

Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com.

Read Article
Vaccine2.jpg (keep)

Methotrexate Impairs COVID Vax Response

MedPage Today

One-third of patients with immune-mediated inflammatory diseases being treated with methotrexate showed attenuated responses to the COVID-19 vaccine, researchers reported.

Read Article
Covid lung pneumonia corona (keep)

Tocilizumab Augmented Efficacy in COVID-19 Pneumonia with High CRP

Jack Cush, MD

JAMA Internal Medicine report an analysis of recent and composite trial data suggesting that tocilizumab (TCZ) therapy in COVID-19–associated pneumonia patients with high CRP levels is likely to be effective.

Read Article
COVID.Flu_.Virus_.jpg (keep)

Factors Associated with COVID-19 Deaths in Rheumatic Patients

Jack Cush, MD

Analysis of data from the COVID-19 Global Rheumatology Alliance shows that rheumatic diseases infected with COVID-19 had a greater risk of death with age, comorbidities, high disease activity and few specific therapies.

Read Article
RheumNow Podcast square

RheumNow Podcast – Myth Busters (5.21.2021)

Jack Cush, MD

Dr Jack Cush reviews the news and journal reports from the past week on RheumNow.com

Read Article
RheumNow Podcast square

RheumNow Podcast – BandAids for Rheumatologists (5.14.2021)

Jack Cush, MD

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com - a website for rheumatologists, by rheumatologists.



We love Rheumatology!

Read Article
RNL, over, microphone

RheumNow Live 2021 Now Available for All

Jack Cush, MD

RheumNow Live (RNL) for 2021 was held March 20 - 21 in Fort Worth, TX, and now all can partake in the meeting - by video, podcast or by signing up for Tuesday Nite Rheumatology (TNR).

Read Article
masks_0.jpg

CDC: Fully Vaccinated Can Shed Masks and Resume Travel

Jack Cush, MD

The U.S.

Read Article
NSAIDs.pills_.caps_.jpg

NSAID Safety with COVID-19 Infection

Jack Cush, MD

NSAIDs do not affect COVID outcomes; here we are nearly 16 months into the pandemic, and this is the common sense conclusion of a recent trial published in Lancet Rheumatology.

Read Article
Preliminary results from 600 pt SAVE-MORE trial in severe COVID, anakinra + standard-of-care was 55% better than SOC in preventing death or respiratory failure; and improving Hosp Discharge by 4 days. Anakinra Rx 100mg/day up to 10 days https://t.co/vbpUMQjC1o

Links:

Dr. John Cush RheumNow ( View Tweet)

News: Factors Associated with COVID-19 Deaths in Rheumatic Patients https://t.co/FzsINtpZEz https://t.co/QzuLZRKaZy

Links:

Dr. John Cush RheumNow ( View Tweet)
News: Factors Associated with COVID-19 Deaths in Rheumatic Patients https://t.co/FzsINtpZEz https://t.co/kDuRvgQ1ni

Links:

Dr. John Cush RheumNow ( View Tweet)
One of our most popular stories-- CDC: Fully Vaccinated Can Shed Masks and Resume Travel https://t.co/K3LYL5w7F8 https://t.co/NlvZsjO2el

Links:

Dr. John Cush RheumNow ( View Tweet)
If any rheums out there have not watched the vaccine town hall by @ACRheum I highly recommend it. A master class on vaccine counseling by @gradydoctor ! Thank you! Thanks @IreneBlancoMD and @DrDavidKarp https://t.co/4ofQVkjKYz via @YouTube

Links:

Jilaine Bolek Berquist BolekBerqui ( View Tweet)

CDC study from 33 sites, 25 states showed vaccine efficacy (against Sx COVID) in HCP was 82% with ONEdose (Pfizer, Moderna) and 94% for TWO doses (same as RCTs). The efficacy of only 1 dose (of a 2 dose COVID vax) is likely to be 70- 82%. https://t.co/uQhUmjSsRd

Links:

Dr. John Cush RheumNow ( View Tweet)

Worth sharing again-- ACR Updates COVID-19 Vaccine Guidance- April 2021 The ACR COVID-19 Vaccine Clinical Guidance was originally published on 2/8/21 & updated on 3/4/21. On 4/28/21, new recommendations were added. https://t.co/BgrFxCgjRw https://t.co/O7ngEBEX6s

Links:

Dr. John Cush RheumNow ( View Tweet)
281,264 people vax w/ Oxford-AstraZeneca COVID vaccine - had 59 VTEs (30 expected; 2 fold incr.) +Higher than expected cerebral VTE seen (excess of 2.5 100K Vax). Thrombocytopenia/coagulation disorders were rare but not in excess. https://t.co/m3cjqkzHSW

Links:

Dr. John Cush RheumNow ( View Tweet)

27 cases of #immune-mediated diseases post #COVIDVaccination ▶️21 had autoimmune/rheumatic background ▶️17 flares, 10 new onset ▶️Average 4 days post #covidvaccine ▶️>80% had resolution, mostly with corticosteroid 👉🏽https://t.co/zHlFziswU7 via @Vaccines_MDPI @MDPIOpenAccess https://t.co/5ifoBmb9Ux

Links:

Dr Ai Lyn Tan DrAiLynTan ( View Tweet)
#VACOLUP study about #COVID19 #vaccine in #lupus = reassuring data for #SLE patients : side-effects are minor/moderate in 80% and the rate of lupus #flare is stable at 3-4%. Thanks to the 571 patients who have already participated 🙏. Link: https://t.co/I0D52fv4BC https://t.co/us0kQlvkVS

Links:

Laurent ARNAUD Lupusreference ( View Tweet)
News Feature: ACR Updates COVID-19 Vaccine Guidance- April 2021 https://t.co/BgrFxCgjRw

Links:

Dr. John Cush RheumNow ( View Tweet)

How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×